You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Psoriatic arthritis
SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kavanaugh A, Vender R, Birt J, et al
SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors
Annals of the Rheumatic Diseases 2017;76:941.